Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome

NCT02544152 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: Lubiprostone
DRUG: Placebo

Sponsor

Sucampo Pharma Americas, LLC

Collaborators

[object Object]
[object Object]